Deciphera Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United…

Drug Manufacturers - Specialty & Generic
US, Waltham [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Deciphera Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Deciphera Pharmaceuticals, Inc. can't present revenue by segment

End of DCPH's Analysis
CIK: 1654151 CUSIP: 24344T101 ISIN: US24344T1016 LEI: - UEI: -
Secondary Listings
DCPH has no secondary listings inside our databases.